Debevoise & Plimpton LLP announces that George “Chip” Nierlich is joining the firm as a partner in the Antitrust Group, based ...

Debevoise & Plimpton LLP announces that Brianna van Kan has joined the firm as a partner in the Intellectual Property & ...

Debevoise & Plimpton LLP announced today that Neal J. Reenan and Ian Bushner have joined the firm as partners in the Mergers ...

Matthew Fishbein is a retired litigation partner whose practice focused on white collar criminal defense, internal investigations and complex commercial ... Read Full Biography Matthew Fishbein is a ...

2025 was an active year for transactions across the global insurance industry. Looking ahead, Debevoise expects to see larger M&A deals, as well as continued active markets for sidecar structures and ...

Expect heightened, coordinated FTC scrutiny across the healthcare sector, as the FTC’s new Healthcare Task Force signals increased, cross-bureau enforcement activity targeting both competition and ...

As we stride full force into 2025, we are taking a moment to reflect on the copyright rollercoaster that was 2024. It was a year of high-stakes showdowns and headline-grabbing drama in the legal world ...

On December 18, 2025, President Trump issued an executive order directing his administration to complete the process for reclassifying marijuana under the federal Controlled Substances Act, moving it ...

On May 27, 2026, DOJ and the CFTC brought the first prediction-markets insider-trading case against a public-company employee, alleging that a Google software engineer profited more than $1.2 million ...

Debevoise & Plimpton LLP is serving as lead transaction counsel to Covetrus, a global animal health and technology and services company and portfolio company of CD&R and TPG, in its merger with MWI ...

Firms should consider implementing a Gen AI governance program that (1) identifies low-risk AI uses cases that do not need a robust compliance review and do not need to be recorded in any AI inventory ...